Groowe Groowe / Newsroom / CING
⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

CING News

Cingulate Inc. Common Stock

Cingulate’s Lead ADHD Candidate CTx-1301 Selected for Podium Presentation at AACAP Annual Meeting

globenewswire.com
CING

FDA Accepts Cingulate’s New Drug Application for CTx-1301 in Attention-Deficit/Hyperactivity Disorder (ADHD) and sets a May 31, 2026 PDUFA Date

globenewswire.com
CING